Havens Advisors’s Acceleron Pharma XLRN Stock Holding History

Havens Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,000	Closed	-$2.41M	–	51
2021 Q3	$2.41M	Buy	+14,000	New	+$1.83M	2.89%	12

Havens Advisors's XLRN Position: Q4 2021 in Review

Havens Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 14,000 shares — an estimated $2.41M sold.

Havens Advisors first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $2.41M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Havens Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Havens Advisors sold 14,000 Acceleron Pharma shares in Q4 2021, an estimated $2.41M.
Havens Advisors first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Havens Advisors's Acceleron Pharma position peaked at $2.41M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Havens Advisors's 13F filing for Q4 2021, filed 31 Jan 2022.